Showing results (601-610 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|October 20, 2011
Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17Masaki Kiga, Fumie Tanzawa, Shiho Iwasaki, et al.
Anti-Cancer Drugs|January 26, 2012
Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphomaQiao Qiao, Yuanjun Jiang, Guang Li
Anti-Cancer Drugs|December 30, 2011
Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptorWeijin Sheng, Yue Shang, Qingfang Miao, et al.
Anti-Cancer Drugs|March 21, 2012
Impressive long-term disease stabilization by nilotinib in two pretreated patients with KIT/PDGFRA wild-type metastatic gastrointestinal stromal tumoursMaria Abbondanza Pantaleo, Margherita Nannini, Maristella Saponara, et al.
Anti-Cancer Drugs|April 7, 2012
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancerAlain Gulenga Musende, Andy Eberding, Catherine A Wood, et al.
Anti-Cancer Drugs|April 19, 2012
Indications for an alternative effective treatment of head and neck squamous cell carcinoma with temsirolimus plus bevacizumab: from bench to bedside?Dimitrios T Trafalis, Constantinos Alifieris, Panayiotis Dalezis, et al.
Anti-Cancer Drugs|February 16, 2012
Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell linesYoshihito Morimoto, Osamu Takeuchi, Asako Takizawa, et al.
Anti-Cancer Drugs|February 9, 2012
Noxa/Mcl-1 balance influences the effect of the proteasome inhibitor MG-132 in combination with anticancer agents in pancreatic cancer cell linesKatrin Naumann, Kathrin Schmich, Christoph Jaeger, et al.
Anti-Cancer Drugs|July 18, 2000
Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patientJ M Gornet, D Azoulay, F Lévi, et al.
Anti-Cancer Drugs|July 18, 2000
Colon carcinoma with synchronous ovarian metastasis--report and discussion of five casesT S Yang, K C Hsu, R Tang, et al.
Pageof 464